• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC UNK_SMART TOUCH UNIDIRECTIONAL SF; CARDIAC ABLATION PERCUTANEOUS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC UNK_SMART TOUCH UNIDIRECTIONAL SF; CARDIAC ABLATION PERCUTANEOUS CATHETER Back to Search Results
Catalog Number UNK_SMART TOUCH UNIDIRECTIONAL
Device Problem Patient Device Interaction Problem (4001)
Patient Problems Hematoma (1884); Cardiac Tamponade (2226); Cardiogenic Shock (2262); Pseudoaneurysm (2605)
Event Date 04/16/2021
Event Type  Injury  
Manufacturer Narrative
This complaint is from a literature source.The following literature cite has been reviewed: cano ó, pérez-roselló v, ayala hd, izquierdo m, osca j, sancho-tello mj, martínez-dolz l.Influence of baseline inducibility and activation mapping on ablation outcomes in patients with structural heart disease and ventricular tachycardia.J cardiovasc electrophysiol.2021 may;32(5):1328-1336.Doi: 10.1111/jce.15035.Epub 2021 apr 16.Pmid: 33834564.No device was received for analysis at the time of submission of the initial 3500a.Since the product was not returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because the lot number was provided by the customer.Manufacturer's reference number: (b)(4).
 
Event Description
"this complaint is from a literature source.The following literature cite has been reviewed: cano ó, pérez-roselló v, ayala hd, izquierdo m, osca j, sancho-tello mj, martínez-dolz l.Influence of baseline inducibility and activation mapping on ablation outcomes in patients with structural heart disease and ventricular tachycardia.J cardiovasc electrophysiol.2021 may;32(5):1328-1336.Doi: 10.1111/jce.15035.Epub 2021 apr 16.Pmid: 33834564.Objective and methods: stand-alone substrate ablation has become a standard ventricular tachycardia (vt) ablation strategy.The authors sought to evaluate the influence of baseline vt inducibility and activation mapping on ablation outcomes in patients with structural heart disease (shd) undergoing vt ablation.The purpose of this single center, observational and retrospective study including 160 consecutive patients with shd and documented vt undergoing ablation between march 2011 and september 2019.Baseline vt induction was attempted before ablation in all patients and vt activation mapping performed when possible.Ablation was guided by activation mapping for mappable vts plus substrate ablation for all patients.Ablation outcomes and complications were evaluated.The patients were divided into three groups according to baseline vt inducibility: group 1 (non inducible, n = 18), group 2 (1 vt morphology induced, n = 53), and group 3 (>1 vt morphology induced, n = 89).Patients who had preexisting hemodynamic instability and/or heart failure were placed on ecmo during the procedure.Lot, model and catalog number are not available, but the suspected biosense webster device possibly associated with reported adverse events: contact-force (cf) ablation catheter: smarttouch, biosense webster.Pentaray multi electrode diagnostic catheter.Smarttouch linear diagnostic catheter.Other biosense webster devices that were also used in this study: n/a.Non-biosense webster devices that were also used in this study: all associated with the lapwi procedure.N/a.Adverse event(s) and provided interventions: 4 instances of cardiac tamponade treated with pericardiocentesis.3 arterial pseudoaneurysms: 2 treated with surgery and 1 treatment unknown.1 femoral hematoma- no treatment required.9 patients with acute hemodynamic decompensation treated with inotropic drugs.Of these 9, two died due to refractory cardiogenic shock associated with lvad implantation and one after cardiac transplantation.The authors do not attribute these deaths to the devices or the procedure.1 patient died after an acute coronary occlusion (proximal left anterior descending artery) during the procedure which was immediately stented but resulting in refractory cardiogenic shock.The manufacturer of the stent was unknown.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK_SMART TOUCH UNIDIRECTIONAL SF
Type of Device
CARDIAC ABLATION PERCUTANEOUS CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
gabriel alfageme
31 technology dr
irvine, CA 92618
9497898687
MDR Report Key12580528
MDR Text Key275185433
Report Number2029046-2021-01674
Device Sequence Number1
Product Code LPB
Combination Product (y/n)N
Reporter Country CodeSP
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 10/05/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/05/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK_SMART TOUCH UNIDIRECTIONAL
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/13/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening;
-
-